Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru-Reference-Cited by-同舟云学术

Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru

Published:2014-12-23 Issue:3 Volume:20 Page:322-325
ISSN:1360-2276
Container-title:Tropical Medicine & International Health
language:en
Short-container-title:Trop Med Int Health

Author:

Otero L.¹²,De Orbegoso A.¹,Navarro A. F.¹,Ríos J.³,Párraga T.¹,Gotuzzo E.¹,Seas C.¹,Van der Stuyft P.²⁴

Affiliation:

1. Instituto de Medicina Tropical Alexander von Humboldt; Universidad Peruana Cayetano Heredia; Lima Peru

2. Unit of General Epidemiology and Disease Control; Department of Public Health; Institute of Tropical Medicine; Antwerp Belgium

3. Dirección de Salud Lima Sur; Ministerio de Salud; Lima Peru

4. Department of Public Health; Ghent University; Ghent Belgium

Funder

Belgian Directorate General for Development Cooperation through an institutional collaboration between the Institute of Tropical Medicine in Antwerp, Belgium

Instituto de Medicina Tropical Alexander von Humboldt in Lima, Peru

Peru ICOHRTA Network for AIDS/TB Research Training National Institutes of Health

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Parasitology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tmi.12430/fullpdf

Reference11 articles.

1. Implementation of Xpert MTB/RIF for routine point-of-care diagnosis of tuberculosis at the primary care level;Clouse;South African Medical Journal,2012

2. Test and treat: a new standard for smear-positive tuberculosis;Davis;Journal of Acquired Immune Deficiency Syndrome,2012

3. The impact of expanded testing for multidrug resistant tuberculosis using genotype MTBDRplus in South Africa: an observational cohort study;Hanrahan;PLoS One,2012

4. Implementation of GenoType MTBDRplus reduces time to multidrug-resistant tuberculosis therapy initiation in South Africa;Jacobson;Clinical Infectious Diseases,2013

5. Ministerio de Salud 2010 Estrategia Sanitaria Nacional para la Prevención y Control de la Tuberculosis www.minsa.gob.pe

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sensitivity and specificity of the mean corpuscular volume and CD4/CD8 ratio in discriminating between rifampicin resistant and rifampicin sensitive tuberculosis;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2020-12

2. Improving outcomes for multi-drug-resistant tuberculosis in the Peruvian Amazon – a qualitative study exploring the experiences and perceptions of patients and healthcare professionals;BMC Health Services Research;2019-08-22

3. Time to treatment for rifampicin-resistant tuberculosis: systematic review and meta-analysis;The International Journal of Tuberculosis and Lung Disease;2017-11-01

4. The effect of early versus late treatment initiation after diagnosis on the outcomes of patients treated for multidrug-resistant tuberculosis: a systematic review;BMC Infectious Diseases;2016-05-04

5. Predominant Mycobacterium tuberculosis Families and High Rates of Recent Transmission among New Cases Are Not Associated with Primary Multidrug Resistance in Lima, Peru;Journal of Clinical Microbiology;2015-03-25